Design and applications of modified oligonucleotides
- PMID: 12563516
- DOI: 10.1590/s0100-879x2003000200001
Design and applications of modified oligonucleotides
Abstract
Oligonucleotides have a wide range of applications in fields such as biotechnology, molecular biology, diagnosis and therapy. However, the spectrum of uses can be broadened by introducing chemical modifications into their structures. The most prolific field in the search for new oligonucleotide analogs is the antisense strategy, where chemical modifications confer appropriate characteristics such as hybridization, resistance to nucleases, cellular uptake, selectivity and, basically, good pharmacokinetic and pharmacodynamic properties. Combinatorial technology is another research area where oligonucleotides and their analogs are extensively employed. Aptamers, new catalytic ribozymes and deoxyribozymes are RNA or DNA molecules individualized from a randomly synthesized library on the basis of a particular property. They are identified by repeated cycles of selection and amplification, using PCR technologies. Modified nucleotides can be introduced either during the amplification procedure or after selection.
Similar articles
-
Therapeutic oligonucleotides.Methods Mol Biol. 2011;764:1-15. doi: 10.1007/978-1-61779-188-8_1. Methods Mol Biol. 2011. PMID: 21748630 Review.
-
Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.Biochem Mol Med. 1997 Oct;62(1):11-22. doi: 10.1006/bmme.1997.2631. Biochem Mol Med. 1997. PMID: 9367793 Review.
-
Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.Chem Soc Rev. 2011 Dec;40(12):5680-9. doi: 10.1039/c1cs15048k. Epub 2011 May 10. Chem Soc Rev. 2011. PMID: 21556437 Review.
-
Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease.BioDrugs. 2003;17(6):383-9. doi: 10.2165/00063030-200317060-00001. BioDrugs. 2003. PMID: 14614761 Review.
-
Therapeutic antisense and ribozymes.Br Med Bull. 1995 Jan;51(1):217-25. doi: 10.1093/oxfordjournals.bmb.a072948. Br Med Bull. 1995. PMID: 7767645 Review.
Cited by
-
Selection of a novel DNA thioaptamer against HER2 structure.Clin Transl Oncol. 2015 Aug;17(8):647-56. doi: 10.1007/s12094-015-1292-0. Epub 2015 May 29. Clin Transl Oncol. 2015. PMID: 26022131
-
Discovery and Proof-of-Concept Study of Nuclease Activity as a Novel Biomarker for Breast Cancer Tumors.Cancers (Basel). 2021 Jan 13;13(2):276. doi: 10.3390/cancers13020276. Cancers (Basel). 2021. PMID: 33451046 Free PMC article.
-
Metal-bipyridine complexes in DNA backbones and effects on thermal stability.J Biol Inorg Chem. 2010 Jun;15(5):629-39. doi: 10.1007/s00775-010-0630-5. Epub 2010 Feb 26. J Biol Inorg Chem. 2010. PMID: 20186448
-
Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.Biochemistry. 2005 Aug 2;44(30):10388-95. doi: 10.1021/bi0507074. Biochemistry. 2005. PMID: 16042416 Free PMC article.
-
Combined Approaches to Site-Specific Modification of RNA.ACS Chem Biol. 2008 Jan 18;3(1):30-37. doi: 10.1021/cb7002225. Epub 2008 Jan 5. ACS Chem Biol. 2008. PMID: 18177002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources